DBV Technologies | Eigenkapital Und Reserven



Equity Capital And Reserves Veränderung Datum
Acadia Pharmaceuticals USD 732.79M 155.61M 2024-12
Alnylam Pharmaceuticals USD 67.09M 34.73M 2024-12
Amarin USD 531.38M 20.5M 2024-09
BioMarin Pharmaceutical USD 5.66B 244.59M 2024-12
DBV Technologies USD 27.4M 26.63M 2024-12
Halozyme Therapeutics USD 363.82M 88.88M 2024-12
Incyte USD 3.45B 276.41M 2024-12
Insmed USD 285.38M 198.04M 2024-12
Ionis Pharmaceuticals USD 588.35M 74.12M 2024-12
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
PTC Therapeutics USD -1098071000 43.72M 2024-12
Sarepta Therapeutics USD 1.53B 306.67M 2024-12
Ultragenyx Pharmaceutical USD 255.3M 91.53M 2024-12
United Therapeutics USD 6.44B 343.1M 2024-12



DBV Technologies Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.